Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: A systematic review and meta-analysis of the literature

Journal of Critical Care

Volumn 29, Issue 1, 2014, Pages 185.e1-185.e7

  Serpa Neto, Ary ^a,b,c   Veelo, Denise P ^a   Peireira, Victor Galvão Moura ^a   de Assunção, Murillo Santucci Cesar ^b   Manetta, José AntÔnio ^a   Espósito, Daniel Crepaldi ^a   Schultz, Marcus J ^c  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Colloid; Crystalloid; Hydroxyethyl starch; Meta analysis; Sepsis

Indexed keywords

CRYSTALLOID INFUSION FLUID; FRESH FROZEN PLASMA; HETASTARCH; INFUSION FLUID; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); CRYSTALLOID; DISEASE ASSOCIATION; DRUG FATALITY; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; PLASMA TRANSFUSION; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SEPSIS; SYSTEMATIC REVIEW; TREATMENT INDICATION;

COLLOID; CRYSTALLOID; HYDROXYETHYL STARCH; META-ANALYSIS; SEPSIS;

ACUTE KIDNEY INJURY; BLOOD TRANSFUSION; CRITICAL ILLNESS; HOSPITAL MORTALITY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INCIDENCE; INTENSIVE CARE; ISOTONIC SOLUTIONS; LENGTH OF STAY; PLASMA SUBSTITUTES; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 85056683911     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.09.031     Document Type: Article

References (25)

1. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39:165-228.
2. Gattas D.J., Dan A., Myburgh J., Billot L., Lo S., Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 2012, 114:159-169.
3. Finfer S., Liu B., Taylor C., et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010, 14:R185.
4. Perel P., Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011, 3:CD000567.
5. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
6. Schortgen F., Lacherade J.C., Bruneel F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357:911-916.
7. McIntyre L.A., Fergusson D., Cook D.J., et al. Fluid resuscitation in the septic shock (FINESS): a feasibility trial. Can J Anesth 2008, 55:819-826.
8. Perner A., Haase N., Guttormsen A.B., et al. Hydroxyethyl starch 130/0.42 versus ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134.
9. Dubin A., Pozo M.O., Casabella C.A., et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010, 25:659-666.
10. Guidet B., Martinet O., Boulain T., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012, 16:R94-R103.
11. Bayer O., Reinhart K., Kohl M., et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med 2012, 40:2543-2551.
12. Myburgh J.A., Finfer S., Bellomo R., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012, 367:1901-1911.
13. Lv J., Zhao H.Y., Liu F., An Y.Z. The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2012, 24:38-41.
14. Zhu G.C., Quan Z.Y., Shao Y.S., Zhao J.G., Zhang Y.T. The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2011, 23:150-153.
15. Basel Starch Evaluation in Sepsis (BaSES) Last verified January 2013. http://clinicaltrials.gov/ct2/show/NCT00273728.
16. Haase N., Perner A., Hennings L.I., et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013, 346:f839-f850.
17. Zarychanski R., Abou-Setta A.M., Turgeon A.F., et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013, 309:678-688.
18. Guyatt G.H., Oxman A.D., Kunz R., et al. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008, 336:995-998.
19. Boyd J.H., Forbes J., Nakada T., Walley K.R., Russell J.A. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011, 39:259-265.
20. Bouchard J., Soroko S.B., Chertow G.M., et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009, 76:422-427.
21. Legrand M., Payen D. Understanding urine output in critically ill patients. Ann Intensive Care 2011, 1:13-20.
22. Moran M., Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987, 317:150-153.
23. Bellmann R., Feistritzer C., Wiedermann C.J. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet 2012, 51:225-236.
24. Bagshaw S.M., Uchino S., Bellomo R., et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007, 2:431-439.
25. SAFE Study Investigators, Finfer S., McEvoy S., Bellomo R., McArthur C., Myburgh J., et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011, 37:86-96.